SCHEMBL30400441

SCHEMBL30400441

CC(C)(C)OC(=O)N1CCC2(CC1)CC(=O)c1ccc(-c3cn(S(=O)(=O)c4ccccc4)c4nc(Cl)ccc34)cc12

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 2/20 0.41
▸ GPR119 Q8TDV5 8/20 0.37
▸ USP30 Q70CQ3 1/20 0.36
▸ MMP2 P08253 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ CCNC P24863 1/20 0.34
▸ CDK8 P49336 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ STS P08842 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ RORC P51449 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26176387 1.00 HTR6 (0.41) HTR6GPR119USP30MMP2MMP13
SCHEMBL26176372 0.77 PTPN11 (0.41) HTR6GPR119MMP2MMP13
SCHEMBL30399794 0.77 PTPN11 (0.41) HTR6GPR119MMP2MMP13
SCHEMBL30623425 0.72 MEN1 (0.46) GPR119USP30HDAC1HDAC8HDAC6
SCHEMBL2187569 0.72 MEN1 (0.46) GPR119USP30HDAC1HDAC8HDAC6
SCHEMBL1221984 0.69 HRH3 (0.51) GPR119USP30HDAC1HDAC8HDAC6
SCHEMBL29562510 0.69 HRH3 (0.51) GPR119USP30HDAC1HDAC8HDAC6
SCHEMBL24723202 0.68 MET (0.48) HTR6GPR119CCNCCDK8STS
SCHEMBL1048604 0.68 BRD4 (0.43) HTR6GPR119USP30STSTGFBR1
SCHEMBL31694099 0.68 ALK (0.42) GPR119USP30HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415817-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP disclosed
WO-2023064349-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO disclosed
Send feedback